ClinicalMetric / Countries / Finland / malignant neoplasm
← 🇫🇮 Finland Trials
🇫🇮 Finland Country × Condition

malignant neoplasm Clinical Trials in Finland

Active clinical trials for malignant neoplasm with research sites in Finland. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇫🇮 Finland

Active Trials in Finland (1)

NCT07252739 Phase 2
Recruiting

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Enrollment
140 pts
Country
🇫🇮 Finland
Merck Sharp & Dohme LLC
View Trial →

Frequently Asked Questions

How many malignant neoplasm clinical trials are active in Finland?
There are currently 1 active clinical trials for malignant neoplasm with sites in Finland, of which 1 are actively recruiting patients.
How can I join a malignant neoplasm clinical trial in Finland?
To join a malignant neoplasm clinical trial in Finland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Finland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are malignant neoplasm trials in Finland?
Active malignant neoplasm trials in Finland span Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Finland Trials → Global malignant neoplasm Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology